PEDEGO Research Unit, University of Oulu, Oulu, Finland; Department of Dermatology and Medical Research Center Oulu, Oulu, Finland.
Unit of General Practice, Oulu University Hospital, Oulu, Finland; Center for Life Course Epidemiology and Systems Medicine, University of Oulu, Oulu, Finland.
J Am Acad Dermatol. 2018 Sep;79(3):514-519. doi: 10.1016/j.jaad.2018.02.067. Epub 2018 Mar 5.
Hidradenitis suppurativa (HS) is associated with various somatic and psychiatric comorbidities. Data regarding comorbidities in young patients with HS are sparse.
We analyzed both somatic and psychiatric comorbidities in young patients in a nationwide HS cohort.
In this retrospective case-control study, data from cases of HS in young (age 5 to <18 years) patients and age-matched controls with benign melanocytic nevi were collected from the Finnish Care Register for Health Care. The prevalence of preselected comorbidities was compared between the HS and control groups.
A total of 153 HS cases were found in the specified age group. Of these, 34.0% had at least 1 somatic comorbidity compared with 4.9% of the controls. At least 1 of the preselected psychiatric diagnoses was present before the age of 18 years in 15.7% of case patients with HS compared with in 5.6% of the controls. By the age of 23 years, 23.5% of the patients with HS and 8.7% of the controls had at least 1 identified psychiatric comorbidity.
Despite this being one of the largest HS cohorts ever studied, the number of young patients with HS was relatively low. Because this was a registry-based study, it was not possible to verify the accuracy of the International Classification of Diseases codes.
Physicians should monitor young patients with HS for both somatic and psychiatric comorbidities.
化脓性汗腺炎（HS）与各种躯体和精神共病有关。关于年轻 HS 患者共病的数据很少。
我们分析了全国性 HS 队列中年轻患者的躯体和精神共病。
在这项回顾性病例对照研究中，从芬兰医疗保健注册中心收集了年轻（5 岁至<18 岁）HS 患者和年龄匹配的良性黑色素瘤痣对照者的 HS 病例数据。比较了 HS 组和对照组之间预先选择的共病的患病率。
在指定年龄组中发现了 153 例 HS 病例。其中，34.0%至少有 1 种躯体共病，而对照组为 4.9%。在 HS 病例患者中，至少有 1 种预选的精神诊断在 18 岁之前存在于 15.7%，而对照组为 5.6%。到 23 岁时，23.5%的 HS 患者和 8.7%的对照组至少有 1 种已识别的精神共病。
尽管这是有史以来研究 HS 患者最多的队列之一，但年轻 HS 患者的数量相对较少。由于这是一项基于登记的研究，无法验证国际疾病分类代码的准确性。
医生应监测年轻 HS 患者的躯体和精神共病。
